Brief: Leap Therapeutics reports Q2 results
Aug 12 (Reuters) - Leap Therapeutics Inc LPTX.O :
* LEAP THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
* LEAP THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.15
* LEAP THERAPEUTICS INC SAYS CASH AND CASH EQUIVALENTS
TOTALED
$90.9 MILLION AT JUNE 30, 2022, EXPECTED TO PROVIDE FINANCIAL
RUNWAY TO MID-2024
Source text for Eikon: ID:nPn1s0KNMa
Further company coverage: LPTX.O
Recent news on Cypherpunk Technologies
See all newsCypherpunk Technologies Inc reports results for the quarter ended June 30 - Earnings Summary
Cypherpunk Technologies swings to Q2 profit on Zcash gains
Cypherpunk Technologies Inc expected to post a loss of 3 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia